Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: A comprehensive review

Potential genotoxic impurities in pharmaceuticals at trace levels are of increasing concern to both pharmaceutical industries and regulatory agencies due to their possibility for human carcinogenesis. Molecular functional groups that render starting materials and synthetic intermediates as reactive...

Full description

Saved in:
Bibliographic Details
Published in:Journal of separation science 2015-03, Vol.38 (5), p.764-779
Main Authors: Reddy, Ambavaram Vijaya Bhaskar, Jaafar, Jafariah, Umar, Khalid, Majid, Zaiton Abdul, Aris, Azmi Bin, Talib, Juhaizah, Madhavi, Gajulapalle
Format: Article
Language:English
Subjects:
Alkyl halides
Communities
Control strategies
Drug Contamination - prevention & control
Drug Industry
Genomics
Genotoxicity
Humans
Impurities
Mathematical analysis
Mutagens - analysis
Pharmaceutical Preparations - analysis
Pharmaceuticals
Regulatory agencies
Regulatory guidance
Strategy
Toxicity
Toxicology
Trace analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Potential genotoxic impurities in pharmaceuticals at trace levels are of increasing concern to both pharmaceutical industries and regulatory agencies due to their possibility for human carcinogenesis. Molecular functional groups that render starting materials and synthetic intermediates as reactive building blocks for small molecules may also be responsible for their genotoxicity. Determination of these genotoxic impurities at trace levels requires highly sensitive and selective analytical methodologies, which poses tremendous challenges on analytical communities in pharmaceutical research and development. Experimental guidance for the analytical determination of some important classes of genotoxic impurities is still unavailable in the literature. Therefore, the present review explores the structural alerts of commonly encountered potential genotoxic impurities, draft guidance of various regulatory authorities in order to control the level of impurities in drug substances and to assess their toxicity. This review also describes the analytical considerations for the determination of potential genotoxic impurities at trace levels and finally few case studies are also discussed for the determination of some important classes of potential genotoxic impurities. It is the authors’ intention to provide a complete strategy that helps analytical scientists for the analysis of such potential genotoxic impurities in pharmaceuticals.
ISSN:1615-9306
1615-9314
DOI:10.1002/jssc.201401143